Nicotine, SSRIs, ACIP, NIH, caffeine: Morning Rounds

2 2 minutes read

Stay informed about the latest developments in health and medicine by subscribing to STAT’s Morning Rounds newsletter, delivered to your inbox every weekday. Sign up now!

Happy Friday!

The recent controversy surrounding The Atlantic’s viral story about measles has sparked discussions among my colleagues. The story, initially presented as a real-life account, turned out to be a composite character based on the author’s research. This revelation has raised questions about transparency and authenticity in journalism.

What are your thoughts on this unfolding situation?

Nicotine undergoes a transformation in the wellness industry

With smoking rates on the decline in the U.S., there is a growing trend in promoting the cognitive and health benefits of nicotine. Wellness influencers and companies are touting nicotine as a natural stimulant, likening it to caffeine and positioning it as a harmless “nootropic” that can enhance performance in various aspects of life.

However, the health claims associated with nicotine are debatable, and its newfound popularity in wellness circles is raising concerns. Discover more about this trend and why tech companies like Palantir are incorporating nicotine products into their offerings in an article by STAT’s Sarah Todd.

FDA to scrutinize antidepressants and RSV treatments

Tracy Beth Høeg, the head of drug regulation at the FDA, has announced plans to closely examine the use of antidepressants in pregnant women and monoclonal antibodies for RSV protection in infants. During her first address to FDA staff, Høeg emphasized the need for more data in pregnant populations and expressed particular interest in women’s health and pregnancy-related issues.

Find out more about Høeg’s agenda and her approach to these contentious topics in an insightful piece by STAT’s Lizzy Lawrence.

States explore new avenues for scientific research funding

Amid fluctuations in NIH funding and policy changes, several states are considering alternative methods to support scientific research. Institutions like UMass Chan Medical School are exploring state funding opportunities to bridge the gap left by federal funding uncertainties, particularly aiding early career faculty and research projects awaiting NIH grants.

Learn about the initiatives in states like New York, Texas, Pennsylvania, and California to bolster research funding at the state level in an in-depth report by STAT’s Anil Oza.

Postponement of ACIP meeting

The scheduled meeting of the Advisory Committee on Immunization Practices (ACIP) has been postponed, as confirmed by a spokesperson for the Department of Health and Human Services. The delay comes amidst a shifting focus within the department and ongoing legal challenges regarding vaccine policies and committee legitimacy.

Stay updated on the developments surrounding the ACIP meeting postponement and the broader implications for vaccine-related discussions in a report by Chelsea Cirruzzo.

Ethical considerations of AI in healthcare

A recent study by Google Health revealed that AI algorithms could outperform radiologists in certain tasks, sparking a debate on the role of AI in clinical decision-making. Experts argue that the focus should be on designing systems that leverage the strengths of both AI and clinicians, rather than viewing it as a competition between the two.

Delve into the ethical implications of AI in healthcare and the importance of integrating technology with clinical expertise in an insightful article by Morish Shah and Ami Bhatt.